PARP inhibition modulates the tumor immune microenvironment in Brca1-deficient ovarian tumor.

被引:0
|
作者
Ding, Liya [1 ]
Wang, Qiwei [1 ]
Kearns, Michael [1 ]
Jiang, Tao [1 ]
Konstantinopoulos, Panagiotis [1 ]
Matulonis, Ursula [1 ]
Zhao, Jean [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA17
引用
收藏
页码:23 / 23
页数:1
相关论文
共 50 条
  • [21] FUNCTIONAL HETEROGENEITY OF ACQUIRED PARP INHIBITOR RESISTANCE IN BRCA1-DEFICIENT CELLS
    Farkkila, Anniina
    Rodriquez, Alfredo
    Olkkonen, Jaana
    Sambel, Larissa
    Dominiquez, Julieta
    Joshi, Niraj
    Clairmont, Connor
    Zhou, Jia
    Lim, Kah-Suan
    Hautaniemi, Sampsa
    D'Andrea, Alan
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 204 - 204
  • [22] The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
    Yue, Wei
    Ma, Jihong
    Xiao, Yinan
    Wang, Pan
    Gu, Xiaoyang
    Xie, Bingteng
    Li, Mo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [23] BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers
    Lei, Guang
    Mao, Chao
    Horbath, Amber D.
    Yan, Yuelong
    Cai, Shirong
    Yao, Jun
    Jiang, Yan
    Sun, Mingchuang
    Liu, Xiaoguang
    Cheng, Jun
    Xu, Zhihao
    Lee, Hyemin
    Li, Qidong
    Lu, Zhengze
    Zhuang, Li
    Chen, Mei-Kuang
    Alapati, Anagha
    Yap, Timothy A.
    Hung, Mien-Chie
    You, Mingjian James
    Piwnica-Worms, Helen
    Gan, Boyi
    CANCER DISCOVERY, 2024, 14 (08) : 1476 - 1495
  • [24] Olaparib and veliparib as effective PARP inhibitors for cancer prevention in a BRCA1-deficient mouse model
    To, Ciric
    Williams, Charlotte R.
    Royce, Darlene B.
    Collins, Ryan M.
    Sporn, Michael B.
    Liby, Karen T.
    CANCER RESEARCH, 2014, 74 (19)
  • [25] OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells
    Baquero, Juan Miguel
    Marchena-Perea, Erik
    Mirabet, Rocio
    Torres-Ruiz, Raul
    Blanco-Aparicio, Carmen
    Rodriguez-Perales, Sandra
    Helleday, Thomas
    Benitez-Buelga, Carlos
    Benitez, Javier
    Osorio, Ana
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Immune Cell Population in Ovarian Tumor Microenvironment
    Cai, Dong Li
    Jin, Li-Ping
    JOURNAL OF CANCER, 2017, 8 (15): : 2915 - 2923
  • [27] Driving Immune Responses in the Ovarian Tumor Microenvironment
    Ning, Franklin
    Cole, Christopher B.
    Annunziata, Christina M.
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [28] Immune Tumor Microenvironment in Ovarian Cancer Ascites
    Almeida-Nunes, Diana Luisa
    Mendes-Frias, Ana
    Silvestre, Ricardo
    Dinis-Oliveira, Ricardo Jorge
    Ricardo, Sara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [29] BROMODOMAIN INHIBITION IN OVARIAN CANCER AND THE TUMOR MICROENVIRONMENT
    Wilson, Andrew J.
    Hoover, Alyssa
    Harris, Whitney
    Liu, Esther
    Khabele, Dineo
    Yull, Fiona E.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 172 - 172
  • [30] Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
    Liu, Jianlin
    Adhav, Ragini
    Miao, Kai
    Su, Sek Man
    Mo, Lihua
    Chan, Un In
    Zhang, Xin
    Xu, Jun
    Li, Jianjie
    Shu, Xiaodong
    Zeng, Jianming
    Zhang, Xu
    Lyu, Xueying
    Pardeshi, Lakhansing
    Tan, Kaeling
    Sun, Heng
    Wong, Koon Ho
    Deng, Chuxia
    Xu, Xiaoling
    NATURE COMMUNICATIONS, 2020, 11 (01)